Company / R&D per Share
Bio-Rad Laboratories R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$9.44
FY2025
5-year range
$8.19 / $9.93
FY2021-FY2025
Trend
-5.0%
vs FY2024
Sector context
#3 of 108
Health Care
What the data says
Among 108 Health Care companies, Bio-Rad Laboratories is in the top 3% for r&d per share. R&D per Share has fluctuated over the past 10 years, ranging from $6.56 in FY2017 to $9.93 in FY2024.
Based on SEC 10-K filings.
9.44 in FY2025 with a 5-year CAGR of +7.4%. Ranks 3rd among 108 companies in Health Care.
Improved from $8.19 to $9.44 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +3.5%
- 5-Year CAGR
- +7.4%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 108This company $9.44 Sector average $2.07
▼
+354.9% above sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 5.0% year-over-year.
- Ranks #3 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.44 | -5.0% |
| FY2024 | $9.93 | +21.3% |
| FY2023 | $8.19 | -3.9% |
| FY2022 | $8.52 | -1.4% |
| FY2021 | $8.63 | +31.0% |
| FY2020 | $6.59 | -2.4% |
| FY2019 | $6.75 | -2.7% |
| FY2018 | $6.94 | +5.7% |
| FY2017 | $6.56 | -13.2% |
| FY2016 | $7.56 | +13.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026